Daiichi Sankyo

Lunit medical AI oncology research collaborations

2 clusters · 5 sources · last updated about 24 hours ago

Latest: Lunit partners with Summit Therapeutics for AI biomarker research

Medical AI company Lunit has announced several research initiatives to advance cancer treatment. At the ESMO 2026 Congress, the company will present findings from its ‘AI forHER’ project, a collaboration with AstraZeneca

Japanese dementia awareness and support initiatives

9 clusters · 18 sources · last updated 13 days ago

Latest: AI advancements target clinical trial efficiency and dementia prevention in Japan

Japan continues to expand regional initiatives focused on dementia screening, consumer protection, and community education. In Akita Prefecture, Akita University has launched screening sessions in Kitaakita City that int

AstraZeneca investment in Summit Therapeutics

2 clusters · 19 sources · last updated 22 days ago

Latest: AstraZeneca invests $2 billion in Summit Therapeutics for cancer drug trials

AstraZeneca has initiated a $2 billion strategic equity investment in Summit Therapeutics through the purchase of convertible preferred stock. This deal is intended to accelerate the development of the investigational PD

Antibody-drug conjugate market development

3 clusters · 6 sources · last updated 24 days ago

Latest: Antibody discovery and ADC development drive oncology innovation

The antibody-drug conjugate (ADC) sector is experiencing significant investment and technological evolution. Individual companies are expanding their capabilities through strategic funding and rights acquisitions, such a

Daiichi Sankyo and Fortis Healthcare legal dispute

2 clusters · 6 sources · last updated 30 days ago

Latest: Fortis Healthcare defends position as Supreme Court allows forensic audit

The legal dispute involving Fortis Healthcare, its former promoters Malvinder Mohan Singh and Shivinder Mohan Singh, and the Japanese pharmaceutical company Daiichi Sankyo has moved toward a forensic investigation of ass